David Shaw’s DICE Therapeutics, Inc. Common Stock DICE Stock Holding History

David Shaw’s Portfolio DICE Stock Details DICE Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q3	–	Sell	-323,453	Closed	-$15M	–	4648
2023 Q2	$15M	Sell	323,453 -232,788	-42%	-$8.05M	0.02%	1051
2023 Q1	$15.9M	Sell	556,241 -126,693	-19%	-$3.75M	0.02%	1038
2022 Q4	$21.3M	Buy	+682,934	New	+$22.3M	0.02%	871
2022 Q2	–	Sell	-10,718	Closed	-$205K	–	5941
2022 Q1	$205K	Sell	10,718 -53,428	-83%	-$954K	﹤0.01%	4854
2021 Q4	$1.62M	Buy	+64,146	New	+$1.88M	﹤0.01%	3539

David Shaw's DICE Position: Q3 2023 in Review

David Shaw sold out of DICE Therapeutics, Inc. Common Stock (DICE) in Q3 2023, closing a stake of 323,453 shares — an estimated $15M sold.

David Shaw first reported a position in DICE in Q4 2021 and held it in 5 quarters. The position peaked at $21.3M in Q4 2022. 0 funds tracked by Wall St. Rank hold DICE as of Q3 2023.

David Shaw reported no remaining DICE Therapeutics, Inc. Common Stock position as of Q3 2023 after selling out during the quarter.
David Shaw sold 323,453 DICE Therapeutics, Inc. Common Stock shares in Q3 2023, an estimated $15M.
David Shaw first reported a position in DICE Therapeutics, Inc. Common Stock in Q4 2021 and held it in 5 quarters.
David Shaw's DICE Therapeutics, Inc. Common Stock position peaked at $21.3M in Q4 2022.
0 funds tracked by Wall St. Rank held DICE Therapeutics, Inc. Common Stock as of Q3 2023.

Based on D.E. Shaw & Co's 13F filing for Q3 2023, filed 14 Nov 2023.